CA 125, CA 15.3, CA 27.29, CEA, β-hCG and α-fetoprotein levels in cyst fluid of breast macrocysts

Objective: To determine the tumoral markers CA 125, CA 15.3, CA 27.29, CEA, β-hCG and α-fetoprotein in serum and breast cystic fluid in women with fibrocystic breast disease. Methods: The study comprised 50 women diagnosed with fibrocystic breast disease but without breast macrocysts, and 60 women w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of gynecology and obstetrics 1995-02, Vol.48 (2), p.187-192
Hauptverfasser: Martínez, L., Castilla, J.A., Blanco, N., Perán, F., Herruzo, A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective: To determine the tumoral markers CA 125, CA 15.3, CA 27.29, CEA, β-hCG and α-fetoprotein in serum and breast cystic fluid in women with fibrocystic breast disease. Methods: The study comprised 50 women diagnosed with fibrocystic breast disease but without breast macrocysts, and 60 women with macrocysts. Results: Significantly higher levels of CA 125, CA 27.29, β-hCG and CEA were observed in the cyst fluid than in the serum of the same patients. According to their K + Na + quotient we found that when K + Na + was 3, only CA 27.29 and β-hCG levels were significantly higher. Comparing cyst fluid marker levels with respect to the K + Na + ratio, the only difference observed was in CA 125 which was significantly greater when K + Na + was < 3. A negative correlation was found between CA 125 and the K + Na + quotient. Conclusion: These results suggest that CA 125 could be used as a marker to identify cyst type.
ISSN:0020-7292
1879-3479
DOI:10.1016/0020-7292(94)02279-8